BioVeda Capital
11
16M
10
0.48
1
0.09
6
- Stages of investment
- Areas of investment
Summary
The company was established in Asia in Singapore. The main department of described VC is located in the Singapore.
Besides them, we counted 4 critical employees of this fund in our database.
The higher amount of exits for fund were in 2019. The fund is constantly included in less than 2 deals per year. This BioVeda Capital works on 15 percentage points more the average amount of lead investments comparing to the other organizations. The top activity for fund was in 2002. The common things for fund are deals in the range of 10 - 50 millions dollars. The average startup value when the investment from BioVeda Capital is 5-10 millions dollars. The real fund results show that this VC is 9 percentage points less often commits exit comparing to other companies.
The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the BioVeda Capital, startups are often financed by Zillionize Angel, University of Manchester, TA Ventures. The meaningful sponsors for the fund in investment in the same round are Temasek Holdings, Yasuda Enterprise Development, Vertex Ventures Southeast Asia & India. In the next rounds fund is usually obtained by Sagamore Bioventures, Openspace Ventures, Morningside Group.
Besides, a startup needs to be aged 2-3 years to get the investment from the fund. Among the most successful fund investment fields, there are Employee Benefits, Financial Services. The fund has specific favorite in a number of founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight ASLAN Pharmaceuticals, MerLion Pharma, CXA Group. For fund there is a match between the location of its establishment and the land of its numerous investments - Singapore.
Investments analytics
Analytics
- Total investments
- 11
- Lead investments
- 1
- Exits
- 6
- Rounds per year
- 0.48
- Follow on index
- 0.09
- Investments by industry
- Biotechnology (6)
- Health Care (5)
- Medical (4)
- Pharmaceutical (3)
- Therapeutics (2) Show 18 more
- Investments by region
-
- United States (5)
- Singapore (5)
- United Kingdom (1)
- Peak activity year
- 2002
- Number of Unicorns
- 1
- Number of Decacorns
- 1
- Number of Minotaurs
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 18
- Avg. valuation at time of investment
- 111M
- Group Appearance index
- 0.91
- Avg. company exit year
- 13
- Avg. multiplicator
- 2.67
- Strategy success index
- 0.50
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
Idun Pharmaceuticals | 15 Jun 2004 | Biotechnology, Therapeutics, Biopharma | Early Stage Venture | 27M | United States, California, San Diego |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.